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PMechanical Dyssynchrony in Congestive Heart Failure
Diagnostic and Therapeutic Implications
Sherif F. Nagueh, MD
Houston, Texas
Myocardial imaging has been successfully applied to the evaluation of patients with heart failure, particularly identify-
ing candidates who are likely to respond to cardiac resynchronization therapy (CRT). Recent studies have shown the
benefits of CRT in heart failure patients with depressed ejection fraction (EF) and a narrow QRS complex, albeit in a
small number of patients, and without a placebo arm. In addition, few reports have noted the presence of pathophysi-
ologically relevant mechanical dyssynchrony in patients with heart failure and normal EF. Collectively, these data sup-
port the need for a better understanding of cardiac function/dysfunction and its treatment in these patient
groups. (J Am Coll Cardiol 2008;51:18–22) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.052w
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wlectrical dyssynchrony leads to mechanical dyssynchrony.
his relation explains in part the presence of left ventricular
LV) dysfunction in a number of patients with congestive heart
ailure. It also accounts for the favorable effects of cardiac
esynchronization therapy (CRT), with respect to reverse LV
emodeling, improved LV function, and, therefore, exercise
olerance and clinical outcome in this population. The QRS
uration is currently used as a surrogate for electromechanical
yssynchrony. However, there are ample data showing the
imitations of using the QRS duration as a surrogate for
echanical dyssynchrony. Excluding patients with a left bun-
le branch block, a wide QRS duration does not necessarily
dentify responders to CRT. In particular, the 20% to 30%
RT failure rate despite a wide QRS complex (1) and the low
ccuracy of this measurement in identifying CRT responders
2) expose the need for a more accurate and clinically applicable
irect measurement of mechanical dyssynchrony that is ame-
able to improvement/correction by CRT. Myocardial imag-
ng has proven extremely valuable in that regard. This com-
entary addresses the opinions expressed in the previous
iewpoint (3), which primarily revolve on imaging methods
or the diagnosis of mechanical dyssynchrony, and whether this
iagnosis, per se, should lead to a recommendation for CRT.
his is a timely topic, and the plethora of available methods
reates the need for a thoughtful and comprehensive analysis of
he literature. As will be noted below, my views agree with
ome, but not all, of the expressed opinions in the Viewpoint
3). In my comment, I will answer 4 key questions, namely the
efinition of mechanical systolic dyssynchrony; its pathophys-
ological consequences and clinical implications in patients
rom TheMethodist DeBakey Heart Center, TheMethodist Hospital, Houston, Texas.
r. Nagueh has served as a consultant for St. Jude Medical and has received lecture feeso
rom speaking at the invitation of Medtronic.
Manuscript received August 15, 2007; accepted August 22, 2007.ith heart failure and depressed EF; its pathophysiological
onsequences and clinical implications in patients with heart
ailure and normal EF; and the clinical application of the
forementioned data.
efinition of Mechanical Dyssynchrony
ntraventricular systolic dyssynchrony refers to differences in
he timing of contraction between the different myocardial
egments. It is important to distinguish dyssynchrony from
yssynergy (“contractile disparity” on the right side of Fig. 1 of
he Viewpoint article by Kass [3]), as well as define what
onstitutes clinically significant dyssynchrony. Dyssynergy re-
ers to differences in function (e.g., peak systolic velocity or
train), but not major differences in timing. Figure 1 shows
xamples of dyssynchrony and dyssynergy. The application of
yocardial imaging is centered on the diagnosis of dyssyn-
hrony, and not dyssynergy.
Normality can be defined as it pertains to function per se, as
ell as from a statistical perspective. There are minor differ-
nces in regional function in normal hearts, both for amplitude
nd timing of contraction. Thus, pathophysiologically relevant
yssynchrony should not be diagnosed unless a certain thresh-
ld is met. This threshold is identified as one that is associated
ith a significant degree of LV dysfunction/clinical events, and
resent in5% of the normal population (both functional and
tatistical components needed). Notwithstanding this defini-
ion, dyssynchrony is not an all-or-none phenomenon, but
xists as a continuous variable with different grades of severity.
t also follows that studies (4) selecting lower cutoff values will
eport a high prevalence of dyssynchrony, as highlighted in
he selected reference (in addition, 80% of the patients in
eference 4 had coronary artery disease with a severely de-
ressed ejection fraction [EF], who likely had multiple regional
all motion abnormalities, and thus the very high prevalence
f dyssynchrony).
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January 1/8, 2008:18–22 Mechanical Dyssynchrony in CHFThere are a number of myocardial imaging techniques
hat have been utilized to identify dyssynchrony, including
-mode, 2-dimensional, and 3-dimensional echocardiography.
owever, most of the available literature has used tissue
oppler, either as color (including tissue synchronization
maging), or pulse wave tissue Doppler. More recently, the
ole of speckle tracking was evaluated. Likewise, there are a
umber of analytic approaches, including time to onset/peak
ystolic ejection velocity, displacement mapping, and defor-
ation measurements. Furthermore, it is possible to acquire
ignals in the longitudinal and cross-sectional planes, and
ot only at rest, but also with exercise. The relative merits of
hese techniques and analyses are beyond the scope of this
omment, and the reader is referred to a more comprehen-
ive review of this topic (5).
The 2 most commonly adopted approaches are the opposite
all delay (measured by comparing time to peak systolic
ontraction between opposite walls by color tissue Doppler
maging), and the standard deviation of the time to peak
ystolic velocity in a 12-segment model, or the Yu index (5).
tatistically, the presence of significant time delay (60 to 65
s between opposite walls, or a Yu index33ms) is associated
ith a clinically significant degree of LV dysfunction, and
ccurs in 5% of the normal population, satisfying both
omponents of the definition (5).
yssynchrony in Patients
ith Systolic Heart Failure
he prevalence of dyssynchrony varies based on the method-
logy, the severity of LV dysfunction, QRS duration, and
oading conditions. Therefore, a single value is not represen-
ative of the whole spectrum. The prevalence is higher in
tudies including patients with larger ventricles, coronary artery
isease, lower EF, and a wide QRS. It ranges from 27% in
Figure 1 Examples of Dyssynchrony and Dyssynergy
(Left) An example of dyssynchrony from a patient with depressed ejection fraction
(Right) An example of dyssynergy. Notice the simultaneous occurrence of peak sy
amplitude. In both panels, yellow arrows indicate time intervals to peak systolic vatients with QRS duration120
s, to 89% in those with QRS
uration 150 ms (6). However,
his does not mean that all these
ases can benefit from CRT as will
e discussed in later text.
With respect to clinical rele-
ance of dyssynchrony indexes,
umerous studies by many labora-
ories (5) have convincingly shown
hat the presence of mechanical
yssynchrony in patients with a
rolonged QRS duration identifies
he clinical and echocardiographic “responders” to CRT. In
hese patients, the improvement in mechanical dyssyn-
hrony is tied to an increase in LV systolic function
using invasive and noninvasive measurements), a reduc-
ion in the severity of mitral regurgitation, reverse LV
emodeling, and in some cases improvement in LV filling
ynamics. Therefore, myocardial imaging has the poten-
ial (still to be realized) to facilitate “individualized”
herapy in this large segment of patients with heart
ailure. I will next address studies in patients with a
ormal QRS duration.
arrow QRS
s noted in the preceding text, intraventricular dyssynchrony is
ot uncommon in heart failure patients with a narrow QRS
omplex. In that regard, 2 recent studies were published
omparing the effects of CRT in this group of patients with the
ffects of CRT on those having a wide QRS complex (7,8).
mportantly, the authors of one of these studies (7) declared
hat all echocardiographic measurements were performed
ithout knowledge of the patients’ clinical status. Collectively,
Abbreviations
and Acronyms
CRT  cardiac
resynchronization therapy
DHF  diastolic heart
failure
EF  ejection fraction
LV  left
ventricle/ventricular
RV  right
ventricle/ventricular
al systolic velocity (blue) occurs 76 ms after septal systolic velocity (yellow).
velocities in these 2 opposite walls, despite a notable difference in the velocity
s.. Later
stolic
elocitie
t
c
i
c
T
A
L
w
o
r
c
a
r
i
d
w
i
i
C
L
c
r
t
a
D
W
U
(
o
a
l
e
s
t
c
t
s
t
t
w
t
g
p
g
s
E
a
e
w
p
f
t
p
i
s
p
g
d
w
a
20 Nagueh JACC Vol. 51, No. 1, 2008
Mechanical Dyssynchrony in CHF January 1/8, 2008:18–22hese 2 reports included 84 patients with a narrow QRS
omplex and showed that CRT results in similar benefits
rrespective of the QRS duration, which showed no significant
orrelation with the time delay measured by tissue Doppler.
he benefits included improvements in New York Heart
ssociation functional class, 6-min walking distance, reverse
V remodeling, and an increase in EF. In one study, CRTwas
ithheld for 4 weeks and resulted in loss of the CRT benefits
n LV function (8).
Both studies have the important limitation of lacking a
andomized design with a placebo group, which is a valid
oncern when considering changes in patients’ symptom-
tology. However, “placebo treatment” does not result in
everse LV remodeling and improvement in EF, as shown
n the randomized MIRACLE (Multicenter InSync Ran-
omized Clinical Evaluation) echocardiographic substudy,
here the analysis was performed without reference to
mages or measurements from other visits (9). Furthermore,
t is LV reverse remodeling that better predicts survival after
RT (10). In addition, as shown in one of the two studies,
V functional improvement is pacing dependent (8). In
onclusion, while the existing studies are not sufficient to
ecommend CRT in this population, they certainly show
he need for additional studies, using a randomized design,
nd powered to address clinically relevant end points.
yssynchrony in Patients
ith Diastolic Heart Failure (DHF)
nlike patients with depressed EF, there are very few studies
11–13) that examined this population, and the true prevalence
f the problem in patients with heart failure and normal EF
waits large epidemiologic studies. Nevertheless, the existing
Figure 2 Systolic Dyssynchrony and Mitral Annulus Velocities F
(Top) An example of systolic dyssynchrony from a patient with heart failure and no
after anteroseptal systolic velocity (blue). (Lower left) Myocardial velocities at sep
systolic (Sa) and early diastolic (Ea) velocities and the markedly reduced Ea/Aa raiterature not only supports its presence, but also its adverse
ffects on cardiac function (Figure 2 and the Online Video
how an example from a patient with DHF). In this popula-
ion, dyssynchrony was defined based on age-matched normal
ontrol groups. Specifically, dyssynchrony was observed in 0%
o 2% of the control group (11,12). Therefore, a rigorous
tatistical standard was applied. It is important to emphasize
hat the cutoff used to define dyssynchrony was not based on
he attempt to identify heart failure patients, but the reverse
as true (i.e., the normal values in the control group were used
o define the prevalence of the problem in the patient groups).
As to the effect of dyssynchrony on cardiac function, our
roup has noted consistent evidence of depressed LV systolic
roperties, and not only longitudinal systolic velocities, in the
roup with DHF and systolic dyssynchrony. Specifically, LV
troke work, slope of stroke work versus end-diastolic volume,
F, ratio of LV end-systolic pressure to end-systolic volume,
nd the ratio of mid-wall fractional shortening to circumfer-
ntial wall stress (11) were all significantly lower in the group
ith systolic dyssnchrony. Furthermore, this group (DHF
atients with systolic dyssynchrony) had the worst LV diastolic
unction measurements (11). Therefore, these findings support
he conclusion that systolic dyssynchrony as defined in the
receding text has pathophysiologically relevant consequences
n patients with DHF, despite a “normal EF,” albeit a
ignificantly lower EF (50s range) in comparison with DHF
atients without systolic dyssynchrony.
Is it possible that inducing further dyssynchrony in this
roup would lead to clinical improvement? While there are no
ata to directly answer this question, our current understanding
ould not lead us to believe so, given the well-documented
dverse effects of right ventricular (RV) apical pacing on
a Patient With Heart Failure and Normal EF
jection fraction (EF). Posterolateral systolic velocity (yellow) occurs 110 ms
nulus. (Lower right) Myocardial velocities at lateral annulus. Notice the reduced
oth sites. Aa  myocardial late diastolic velocity.rom
rmal e
tal an
tio at b
c
a
s
h
a
n
g
F
t
t
E
r
c
p
n
p
w
p
f
h
g
V
w
D
r
D
F
i
d
a
n
(
c
s
p
c
m
p
C
p
m
p
n
C
T
p
c
b
a
i
p
d
c
a
d
w
d
s
c
I
d
d
s
r
i
c
p
w
m
w
t
c
s
c
c
e
w
t
s
t
e
v
t
a
o
r
R
t
w
h
a
s
s
n
c
i
p
a
L
d
s
r
a
o
f
21JACC Vol. 51, No. 1, 2008 Nagueh
January 1/8, 2008:18–22 Mechanical Dyssynchrony in CHFardiac function, including decreasing the EF to values50%,
nd further impairing LV diastolic function (14). In fact, one
tudy (15) showed that RV apical pacing increases the risk of
eart failure hospitalizations and atrial fibrillation (even when
trioventricular synchrony is maintained) in patients with a
ormal QRS duration and a median EF of 55% (similar to the
roup with systolic dyssynchrony studied by Wang et al. [11]).
urthermore, the results of a recent randomized multicenter
rial that are pertinent to this discussion were published (16). In
his study in 1,065 patients with sinus node disease and normal
F (mean 58 10%), the effect of minimal RV pacing (which
educes the duration of dyssynchrony caused by RV pacing) on
linical events was compared with conventional dual-chamber
acing (99% of ventricular beats were RV paced). The study
oted that minimal RV pacing, and therefore fewer periods of
acing-induced dyssynchrony (only 9% of ventricular beats
ere paced), results in a significantly lower incidence of
ersistent atrial fibrillation, ablation procedures, and heart
ailure hospitalizations (16). In light of the preceding text, one
as to seriously question whether further dyssynchrony is a
ood treatment strategy in these patients. The argument in the
iewpoint (3) about the beneficial effects of RV pacing (study
ith 9 patients) in patients with EF70% is not applicable to
HF patients with systolic dyssynchrony, and EF in the 50s
ange.
iastolic Dyssynchrony
or this topic, my views are mostly similar to those expressed
n the Viewpoint (3), and are herein summarized. Diastolic
yssynchrony is common in patients with heart failure, and
ppears to have an important contribution to their hemody-
amic and clinical status (11). As we and others have shown
11,17), loading conditions have a strong influence on dyssyn-
hrony. However, aside from load, LV hypertrophy has a
trong association with dyssynchrony. These observations sup-
ort the recommendation for the need to achieve adequate
ontrol of hypertension in patients with DHF, preferably with
edications that can also result in regression of LV hypertro-
hy and interstitial fibrosis. At this time, it is unknown how
RT affects diastolic dyssynchrony in this population, but, as
reviously discussed (11), CRT may not be a viable treatment
odality for diastolic dyssynchrony, given the multiple patho-
hysiological mechanisms that contribute to it, and that may
ot be favorably affected by CRT.
linical Application of Myocardial Imaging to CRT
here are 2 points to address here. The first deals with the
erception that imaging detects abnormalities that are not
linically significant, much similar to trace regurgitant lesions
y color Doppler. Trace regurgitation occurs in normal hearts
nd has no impact on cardiac function, or survival. As detailed
n the previous paragraphs, and conceded in part in the
revious Viewpoint (3), significant mechanical dyssynchrony
oes not occur in normal hearts, has serious adverse effects on
ardiac function, and provides important outcome data, which ore independent of many other variables (including QRS
uration) in patients with prolongedQRS (18), as well as those
ith a normal QRS duration (19). Therefore, there are striking
ifferences when one considers what trace regurgitation repre-
ents, and what mechanical dyssynchrony (as defined in this
omment) by myocardial imaging means.
The second point is how to use the imaging data clinically.
will indicate up front that many cases with mechanical
yssynchrony are not candidates for CRT, and that imaging
ata should not be the sole determinant of who should, or
hould not, receive CRT. Dyssynchrony occurs for several
easons, including electrical delay, myocardial ischemia and
nfarction, and abnormal loading conditions. To identify the
ases that can potentially benefit from CRT, it is essential to
erform the echocardiographic study after medical therapy—
hich reduces afterload—has been optimized. This recom-
endation is in line with the approved indications for CRT,
here patients are not considered candidates until medical
herapy has been optimized (beta-blockers, angiotensin-
onverting enzyme inhibitors/angiotensin receptor blockers,
pironolactone, and nitrates  hydralazine in African Ameri-
ans), and is supported by recent reports showing the effects of
ardiac medications on dyssynchrony measurements (11,17).
Second, a comprehensive echocardiographic evaluation by
xperienced personnel is needed. Sonographers and physicians
ho perform and interpret these studies need to have adequate
raining (attendance of few courses without adequate demon-
tration of competence is not sufficient), and maintain compe-
ence by doing/interpreting a reasonable number of studies
ach year. Aside from image acquisition, the analysis can be
ery challenging when one considers the small signal ampli-
udes, the myriad of abnormal conduction patterns that exist,
nd the confounding variables of regional dysfunction because
f previous myocardial infarction. The recently announced
esults of the PROSPECT (Predictors of Response to Cardiac
e-Synchronization Therapy) trial highlight the challenges
hat can be present in these exams and their interpretation,
hich were pointed out in the Viewpoint (3) (no disagreement
ere). However, rather than abandoning a sound and logical
pproach to “individualized” therapy, the PROSPECT trial
hould fuel the search for more robust methods with higher
pecificity to diagnose dyssynchrony, which at this time should
ot be considered as a routine test that can be performed in any
linical laboratory.
From an analysis perspective, each of the single indexes has
ts limitations. For an example, an increased Yu index may be
resent because of mid/apical akinesis/dyskinesis, but without
significant systolic time delay between the basal segments.
ikewise, a systolic time delay between basal segments may be
ue to the presence of a myocardial scar. In both scenarios, the
pecificity of mechanical dyssynchrony for the prediction of
everse remodeling is low (20). However, one can entertain
pproaches that include more than one index, for example the
pposite wall delay and the Yu index together. The rationale
or such an approach stems from identifying both the location
f delayed contraction and the global impact it has on dyssyn-
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Mechanical Dyssynchrony in CHF January 1/8, 2008:18–22hrony. Alternatively, the combination of longitudinal and
adial dyssynchrony could be utilized, and a recent study (21)
as shown that method to be highly promising.
A clinically useful echocardiographic evaluation should
dentify the presence of regional dysfunction and scar tissue
diagnosed by reduced wall thickness and increased brightness,
ut additional imaging modalities may be needed when in
oubt). It is also advantageous to note the site with the latest
ctivation before lead implantation. The results may dissuade
rom the procedure altogether, for example in the setting of
eptal, as opposed to free wall delay, as CRT (with lead
mplantation aimed at earlier activation of LV free wall) in this
etting is not necessarily helpful. Alternatively, the echocardio-
raphic findings can confirm the presence of latest contraction
t a site that is amenable to improvement by CRT, to the
xtent that this is technically feasible.
onclusions
yocardial imaging offers unique insights into the evaluation
f mechanical dyssynchrony in heart failure patients. The
rguments about the high prevalence and “imperfect tech-
ique” are valid points to discuss. However, myocardial imag-
ng can play a critical role in selected groups, and is here to stay.
hile the technique is not perfect, we are moving towards a
etter understanding of its advantages and limitations, with
romising ongoing developments.
Recently, the RethinQ (Cardiac Resynchronization
herapy in Patients with Heart Failure and Narrow QRS)
tudy was published looking at CRT in 172 patients with
eart failure (EF 35%), and a narrow QRS complex, but
ith mechanical dyssynchrony, with the majority of patients
96%) enrolled based on the opposite wall delay method by
olor tissue Doppler imaging (22). In this randomized
ouble-blind study, CRT did not result in a significant
hange in peak oxygen consumption (primary end point),
innesota Living With Heart Failure score, 6-min walk,
nd LV volumes/EF at 6 months. The potential reasons for
hese results include problems with the echocardiographic
ethods used to identify patients, issues with lead place-
ent as it relates to the site with latest contraction and scar
issue, and the actual possibility that dyssynchrony in this
opulation is not due to a conduction delay that can be
orrected by CRT (as stated in the Viewpoint by Kass [3]).
ending analysis aimed at dissecting these possibilities, and
dditional studies, caution is warranted for considering
RT in this population.
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ethodist DeBakey Heart Center, 6550 Fannin, SM-677, Hous-
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